Erratum: Distinct demographic factors influence the acceptance of vaccination against HPV (Arch Gynecol Obstet, DOI 10.1007/s00404-015-3614-4);Distinct demographic factors influence the acceptance of vaccination against HPV

Archives of Gynecology and Obstetrics

Volumn 292, Issue 1, 2015, Pages 197-205

  Agorastos, Theodoros ^a   Chatzistamatiou, Κimon ^a,d   Zafrakas, Μenelaos ^b   Siamanta, Vagia ^a   Katsamagkas, Taxiarchis ^a   Constantinidis, Theodoros ^c   Lampropoulos, Αlexandros ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d NONE   (Greece)

Author keywords

Cervical cancer prevention; Demographic factors; HPV male and female vaccination acceptance; Human papillomavirus vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDY; FEMALE; GREECE; HUMAN; MALE; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; PROSPECTIVE STUDY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; VACCINATION; VAGINA SMEAR; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; VACCINATION; VAGINAL SMEARS; YOUNG ADULT;

EID: 84939934403     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3631-3     Document Type: Erratum

References (34)

1. zur Hausen H (2009) Papillomaviruses in the causation of human cancers—a brief historical account. Virology 384(2):260–265. doi:10.1016/j.virol.2008.11.046
2. Dürst M, Gissmann L, Ikenberg H, zur Hausen H (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80(12):3812–3815
3. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H (1984) A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3(5):1151–1157
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12:AID-PATH431>3.0.CO;2-F
5. zur Hausen H (1996) Papillomavirus infections–a major cause of human cancers. Biochim Biophys Acta 1288(2):F55–F78
6. Lajer CB, von Buchwald C (2010) The role of human papillomavirus in head and neck cancer. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 118(6–7):510–519. doi:10.1111/j.1600-0463.2010.02624.x
7. Poljak M (2012) Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges. Clin Microbiol Infect 18(Suppl 5):64–69. doi:10.1111/j.1469-0691.2012.03946.x
8. Schiller JT, Castellsagué X, Garland SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123–F138. doi:10.1016/j.vaccine.2012.04.108
9. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.3322/caac.20107
10. Muñoz N, Kjaer SK, Sigurdsson K, Iversen O-E, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson S-E, Tang GWK, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KED, Sings HL, James MK, Hesley TM, Barr E, Haupt RM (2010) Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 102(5):325–339. doi:10.1093/jnci/djp534
11. Agorastos T, Chatzigeorgiou K, Brotherton JML, Garland SM (2009) Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far. Vaccine 27(52):7270–7281. doi:10.1016/j.vaccine.2009.09.097
12. Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T, Group LS (2012) Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine. Arch Gynecol Obstet 285(6):1719–1724. doi:10.1007/s00404-011-2208-z
13. Chatzistamatiou K, Sotiriadis A, Agorastos T (2013) Letter to the editor referring to the manuscript entitled: “Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine” reported by Sotiriadis et al. (Arch Gynecol Obstet. 2012 Jun;285(6):1719–24). Arch Gynecol Obstet. doi:10.1007/s00404-013-3010-x
14. Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, Lampropoulos AF, group Ls, (2014) Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study. Eur J Cancer Prev Off J Eur Cancer Prev Organ (ECP). doi:10.1097/CEJ.0000000000000060
15. Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, Nicula F, Vass L, Valerianova Z, Voti L, Sauvaget C, Ronco G (2009) Cervical cancer screening policies and coverage in Europe. Eur J Cancer 45(15):2649–2658. doi:10.1016/j.ejca.2009.07.020
16. Kroupis C, Thomopoulou G, Papathomas TG, Vourlidis N, Lazaris AC (2007) Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiol Infect 135(6):943–950. doi:10.1017/S095026880700876X
17. Rashid RM, Dahlui M, Mohamed M, Gertig D (2013) Adapting the Australian system: is an organized screening program feasible in Malaysia?–an overview of cervical cancer screening in both countries. Asian Pac J Cancer Prev APJCP 14(3):2141–2146
18. Donadiki EM, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, Velonakis EG (2012) Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake. Vaccine 30(49):6967–6970. doi:10.1016/j.vaccine.2012.09.028
19. Hopkins TG, Wood N (2013) Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine 31(13):1673–1679. doi:10.1016/j.vaccine.2013.01.028
20. Dursun P, Altuntas B, Kuscu E, Ayhan A (2009) Women’s knowledge about human papillomavirus and their acceptance of HPV vaccine. Aus N Z J Obstet Gynaecol 49(2):202–206. doi:10.1111/j.1479-828X.2009.00947.x
21. Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL, Ehlen TG, Dobson SR, Money DM, Patrick DM (2007) Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ 177(12):1506–1512. doi:10.1503/cmaj.071022
22. Charakorn C, Rattanasiri S, Lertkhachonsuk A-a, Thanapprapasr D, Chittithaworn S, Wilailak S (2011) Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women. Asia Pac J Clin Oncol 7(2):160–167. doi:10.1111/j.1743-7563.2011.01392.x
23. Brabin L, Roberts SA, Farzaneh F, Kitchener HC (2006) Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24(16):3087–3094. doi:10.1016/j.vaccine.2006.01.048
24. Crosignani P, De Stefani A, Fara GM, Isidori AM, Lenzi A, Liverani CA, Lombardi A, Mennini FS, Palu G, Pecorelli S, Peracino AP, Signorelli C, Zuccotti GV (2013) Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health. doi:10.1186/1471-2458-13-642
25. Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M (2013) Inequalities in the uptake of Human Papillomavirus Vaccination: a systematic review and meta-analysis. Int J Epidemiol. doi:10.1093/ije/dyt049
26. Constantine NA, Jerman P (2007) Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 40(2):108–115. doi:10.1016/j.jadohealth.2006.10.007
27. Davis K, Dickman ED, Ferris D, Dias JK (2004) Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 8(3):188–194
28. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE (2005) Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 159(2):132–137. doi:10.1001/archpedi.159.2.132
29. Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA (2008) Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 43(3):239–245. doi:10.1016/j.jadohealth.2008.06.009
30. Liddon NC, Hood JE, Leichliter JS (2012) Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006–2008 National Survey of Family Growth. Vaccine 30(16):2676–2682. doi:10.1016/j.vaccine.2012.02.007
31. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC (2006) Are women ready for the HPV vaccine? Gynecol Oncol 103(1):151–154. doi:10.1016/j.ygyno.2006.02.003
32. Polonijo AN, Carpiano RM (2013) Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory. Soc Sci Med 82:115–125. doi:10.1016/j.socscimed.2012.12.020
33. Chatzistamatiou K, Katsamagkas T, Zafrakas M, Zachou K, Orologa A, Fitsiou F, Theodoridis T, Konstantinidis T, Konstantinidis T, Agorastos T (2013) Smoking and genital human papilloma virus infection in women attending cervical cancer screening in Greece. World J Obstet Gynecol 2(3):53–61. doi:10.5317/wjog.v2.i3.53
34. Kwan TTC, Chan KKL, Yip AMW, Tam KF, Cheung ANY, Lo SST, Lee PWH, Ngan HYS (2009) Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications. BJOG 116(4):501–510. doi:10.1111/j.1471-0528.2008.01988.x